paroxetine has been researched along with amitriptyline in 131 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (13.74) | 18.7374 |
| 1990's | 32 (24.43) | 18.2507 |
| 2000's | 48 (36.64) | 29.6817 |
| 2010's | 26 (19.85) | 24.3611 |
| 2020's | 7 (5.34) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Bosch, A; Del Castillo, JC; Del Río, J; Heras, B; Lasheras, B; Martínez-Esparza, J; Monge, A; Mourelle, M; Oficialdegui, AM; Orús, L; Palop, JA; Pérez-Silanes, S; Roca, J; Tordera, R | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Boriss, H; Braggio, S; Corbioli, S; Fontana, S; Helmdach, L; Longhi, R; Schiller, J; Vinco, F | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Möller, HJ; Steinmeyer, EM | 1 |
| Bignamini, A; Rapisarda, V | 1 |
| Clarke, A; Hutchinson, DR; Moon, CA; Tong, S; Vince, M | 1 |
| Kuhs, H; Rolf, LH; Rudolf, GA; Schlake, HP | 1 |
| Bowery, NG; Johnson, AM; Nelson, DR; Palmer, KJ; Pratt, GD | 1 |
| Clissold, SP; Dechant, KL | 1 |
| Johnson, AM; Nelson, DR; Palmer, KJ | 1 |
| Kuhs, H; Rudolf, GA | 2 |
| Byrne, MM | 1 |
| Bascara, L | 1 |
| Brune, GG; Husstedt, IW; Kuhs, H; Rudolf, GA | 1 |
| Bosse, T; Brune, GG; Kuhs, H; Rolf, LH; Rudolf, GA; Schlake, HP; Schuhknecht, E | 1 |
| Johnson, AM; Nelson, DR; Thomas, DR | 1 |
| Cain, CR; Hamilton, TC; Norton, J; Petersen, EN; Poyser, RH; Thormählen, D | 1 |
| Dana-Haeri, J; Sinclair, AJ; Warrington, SJ | 1 |
| Hassan, SM; Turner, P; Wainscott, G | 2 |
| Jackson, D; McClelland, GR; Raptopoulos, P | 1 |
| Galzin, AM; Langer, SZ; Moret, C; Verzier, B | 1 |
| Hamilton, TC; Norton, J; Poyser, RH; Thormählen, D | 1 |
| Briley, M; Moret, C | 1 |
| Ishikura, Y; Ono, H; Yokota, S | 1 |
| Furuya, Y; Man'no, K; Ohno, M; Ohta, H; Sugihara, K; Tani, Y; Ueki, S; Watanabe, S | 1 |
| Laursen, AL; le Fèvre Honoré, P; Mikkelsen, PL; Rasmussen, S | 1 |
| Battegay, R; Hager, M; Rauchfleisch, U | 1 |
| Detroux, D; Kerkhofs, M; Leyman, S; Linkowski, P; Mendlewicz, J; Staner, L | 1 |
| O'Hanlon, JF; Robbe, HW | 1 |
| Fartacek, R; Geretsegger, C; Heim, M; Mair, M; Platz, T; Stuppaeck, CH | 1 |
| Gagiano, CA | 1 |
| Hirschfeld, RM | 1 |
| Rechlin, T | 1 |
| Fleischhacker, WW; Geretsegger, C; Hinterhuber, H; König, P; Platz, T; Schubert, H; Stuppaeck, CH; Whitworth, AB | 1 |
| Claus, D; Rechlin, T; Weis, M | 1 |
| Cadogan, AK; Kendall, DA; Marsden, CA; Tulloch, I | 1 |
| Berzewski, H; Eckmann, F; Gonzalves, N; Kissling, W; Knorr, W; Magyar, I; Möller, HJ; Ressler, P; Rudolf, GA; Steinmeyer, EM | 1 |
| Hunter, KD; Wilson, WS | 1 |
| Behnke, K; Black, CH; Bork-Rasmussen, H; Christiansen, PE; Nilsson, J; Ohrström, JK | 1 |
| Cowen, PJ; McTavish, SF; Williamson, DJ | 1 |
| Castronovo, V; Ferini-Strambi, L; Montorsi, F; Oldani, A; Rigatti, P; Smirne, S; Zucconi, M | 1 |
| Bourin, M; Pinot, P; Redrobe, JP | 1 |
| Gartside, SE; Sharp, T; Umbers, V | 1 |
| Gray, AM; Sewell, RD; Spencer, PS | 1 |
| Ellison, Z; Evans, CL; Fombonne, E; Ha, Y; Saisch, S | 1 |
| Kelly, PA; Noble, J; Olsson, T; Seckl, JR; Yau, JL | 1 |
| Bauer, M; Meister, W; Müller-Oerlinghausen, B; Zaninelli, R | 1 |
| Freed, E; Goldney, R; Johnston, R; Lambert, T; Tiller, J | 1 |
| Gray, AM; Pache, DM; Sewell, RD | 1 |
| Galin, RS; Robison, LM; Sclar, DA; Skaer, TL | 1 |
| Fujiseki, Y; Inagaki, C; Kinoshita, T; Okugawa, G; Omori, K; Suzukawa, J | 1 |
| Antonietti, M; Denis, P; Ducrotte, P; Lalaude, O; Leroi, AM; Menard, JF; Touchais, JY | 1 |
| Contu, A; Gutschow, K; Möslinger-Gehmayr, R; Oberhoff, C; Schindler, AE; Staab, HJ; Zaninelli, R | 1 |
| Haack, M; Hinze-Selch, D; Kraus, T; Kühn, M; Pollmächer, T; Schuld, A; Uhr, M | 1 |
| Deslandes, PN; Pache, DM; Sewell, RD; Subhan, F | 1 |
| Bird, H; Broggini, M | 1 |
| Barnett, W; Fritzsche, M; Richter, P; Sattler, HD; von Turner, A | 1 |
| Draganich, LF; Karrison, T; Klafta, J; Zacny, J | 1 |
| Colla, M; Dempfle, CE; Deuschle, M; Heuser, I; Lederbogen, F; Weber, B | 1 |
| Bauer, M; Jobert, M; Müller-Oerlinghausen, B; Zaninelli, R | 1 |
| Colla, M; Deuschle, M; Gernoth, C; Heuser, I; Kniest, A; Lederbogen, F; Weber, B | 1 |
| Goicoechea, C; Martín, MI; Ormazábal, MJ; Sánchez, E | 1 |
| Contu, A; Moslinger-Gehmayr, R; Pezzella, G | 1 |
| Deuschle, M; Henning, O; Heuser, I; Kniest, A; Niedermaier, N | 1 |
| Kenemans, JL; Trooster, S; van Laar, MW; van Megen, HJ; Verbaten, MN; Volkerts, ER | 1 |
| Arbuzov, AL; Khurbatova, IG; Kutushev, OT; Litvintsev, SV; Martyniuk, IuL; Reznik, AM | 1 |
| Colla, M; Deuschle, M; Hamann, B; Heuser, I; Kniest, A; Krumm, B; Lederbogen, F; Meichel, C | 1 |
| Deuschle, M; Hellweg, R; Heuser, I; Hörer, E; Lederbogen, F | 1 |
| Hale, AS | 1 |
| Cordingley, GE; Holroyd, KA; Labus, JS; O'Donnell, FJ | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
| Jick, H; Jick, SS; Kaye, JA | 1 |
| Deuschle, M; Gilles, M; Henn, FA; Heuser, I; Kopf, D; Lederbogen, F; Lehnert, H; Luley, CW; Ritter, S; Weber-Hamann, B; Westphal, S | 1 |
| Deuschle, M; Gilles, M; Hamann, B; Heuser, I; Luppa, P | 1 |
| Colla, N; Deuschle, M; Erb-Bies, M; Hamann, B; Heuser, I; Kniest, A; Niemann, H | 1 |
| Bindeballe, N; Colla, M; Deuschle, M; Gilles, M; Hamann, B; Heuser, I; Krumm, B; Lederbogen, F | 1 |
| Barbui, C | 1 |
| Goldney, RD | 1 |
| Altamirano, AV; Frazer, A; Gould, GG; Javors, MA | 1 |
| Gorodnichev, AV; Kostiukova, EG; Mosolov, SN; Timofeev, IV | 1 |
| Bohrer, M; Colla, M; Deuschle, M; Hagen, T; Heuser, I; Kronenberg, G; Meichel, K | 1 |
| Bertschy, G; Bondolfi, G; Golaz, J; Rachid, F | 1 |
| Aldushin, AA; Avedisova, AS; Brodin, VI | 1 |
| Deuschle, M; Gilles, M; Heuser, I; Lederbogen, F; Weber-Hamann, B | 1 |
| Dingwall, K; Douglas, J; Jorgenson, G; Smith, SS | 1 |
| Gross, G; Groth, I; Jongen-Relo, A; Rex, A; Wicke, KM | 1 |
| Deuschle, M; Hellweg, R; Heuser, I; Ziegenhorn, A | 1 |
| Ebe, K; Iidaka, T; Ishihara, R; Iwamoto, K; Kawamura, Y; Nakamura, Y; Noda, A; Noda, Y; Ozaki, N; Takahashi, M; Uchiyama, Y; Yoshida, K | 1 |
| Billups, SJ; Delate, T; Dugan, D | 1 |
| Andersohn, F; Garbe, E; Schade, R; Suissa, S | 1 |
| Aburakawa, Y; Aizawa, H; Hasebe, N; Kwak, S; Sawada, J; Yamashita, T | 1 |
| Bauer, M; Lewitzka, U; Pilhatsch, M; Winter, C; Wolf, R | 1 |
| Deuschle, M; Gilles, M; Hamann, B; Heuser, I; Kopf, D; Lederbogen, F; Paslakis, G; Westphal, S | 1 |
| Crnobaric, C; Kecojevic-Miljevic, S; Lecic-Tosevski, D; Miljevic, CD | 1 |
| Baldo, P; Cecco, S; Doree, C; McFerran, D; Molin, P | 1 |
| Blum, WF; Colla, M; Daseking, E; Deuschle, M; Gilles, M; Heuser, I; Kopf, D; Krumm, B; Lederbogen, F; Schilling, C; Weber-Hamann, B; Wudy, SA | 1 |
| Hara, Y; Iidaka, T; Iwamoto, K; Kojima, J; Miyata, S; Noda, A; Ozaki, N; Takahashi, M | 1 |
| Balsevich, G; Dedic, N; Deussing, JM; Eder, M; Gassen, NC; Hafner, K; Hartmann, J; Holsboer, F; Ising, M; Kirmeier, T; Kloiber, S; Kollmannsberger, L; Lucae, S; Rein, T; Schmidt, MV; Stepan, J; Uhr, M; Wagner, KV; Zellner, A; Zschocke, J | 1 |
| Gassen, NC; Hartmann, J; Rein, T; Schmidt, MV | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Miskovic, M | 1 |
| Cantrell, SE; Häuser, W; Nishishinya, MB; Urrútia, G; Walitt, B | 1 |
| Ramzy, EA | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Chen, DY; Gu, X; Jia, L; Jiang, SM; Xie, HL; Xu, J | 1 |
| Chen, DY; Jia, L; Jiang, SM; Liu, J; Liu, Y; Xu, J; Yang, M; Zhou, WC | 1 |
| Chen, DY; Jia, L; Jiang, SM; Liu, Y; Song, JS; Xu, J | 1 |
| Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA | 1 |
| Alsaab, S; Cobb, C; Haidari, M; Mansani, S; Ponds, D; Romero, L | 1 |
| Altunkaynak, BZ; Deniz, OG; Guzel, H; Ilkaya, F; Kokcu, A; Kurtoglu Ozdes, E | 1 |
| Holper, L | 1 |
| Ipser, JC; Phillips, NJ; Stein, DJ; Williams, T | 1 |
| Bracke, F; Frieling, H; Leffler, A | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Mortazavi, P; Motafeghi, F; Shahsavari, R; Shokrzadeh, M | 1 |
| Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
10 review(s) available for paroxetine and amitriptyline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
Topics: Amitriptyline; Animals; Antidepressive Agents; Clomipramine; Depressive Disorder; Drug Evaluation; Drug Tolerance; Humans; Imipramine; Paroxetine; Piperidines; Serotonin Antagonists | 1991 |
Guidelines for the long-term treatment of depression.
Topics: Adult; Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Middle Aged; Paroxetine; Placebos; Psychotherapy; Recurrence; Time Factors; Treatment Outcome | 1994 |
Antidepressants for patients with tinnitus.
Topics: Amitriptyline; Antidepressive Agents; Depression; Humans; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tinnitus; Trazodone; Trimipramine | 2012 |
Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
Topics: Amitriptyline; Citalopram; Fibromyalgia; Fluoxetine; Humans; Melatonin; Musculoskeletal Pain; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Syndrome | 2015 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Antidepressant pharmacogenetics in children and young adults: A systematic review.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult | 2019 |
Pharmacotherapy for post traumatic stress disorder (PTSD).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Humans; Middle Aged; Mirtazapine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Young Adult | 2022 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
51 trial(s) available for paroxetine and amitriptyline
| Article | Year |
|---|---|
Facet theoretic analysis of the Hamilton-D scale.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Models, Statistical; Paroxetine; Personality Inventory; Piperidines; Prospective Studies; Psychometrics; Serotonin Antagonists | 1992 |
A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales | 1992 |
Paroxetine in the treatment of elderly depressed patients in general practice: a double-blind comparison with amitriptyline.
Topics: Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales | 1992 |
Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents; Blood Platelets; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1992 |
Cardiovascular effects of paroxetine.
Topics: Adult; Amitriptyline; Antidepressive Agents; Blood Pressure; Double-Blind Method; Electrocardiography; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Paroxetine; Piperidines | 1990 |
Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Evaluation; Female; Hospitals, Psychiatric; Humans; Male; Meta-Analysis as Topic; Middle Aged; Paroxetine; Piperidines; Randomized Controlled Trials as Topic; Serotonin Antagonists | 1989 |
A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients.
Topics: Adult; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists | 1989 |
A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Humans; Paroxetine; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Serotonin Antagonists | 1989 |
Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
Topics: Adult; Amitriptyline; Antidepressive Agents; Blood Platelets; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Paroxetine; Piperidines; Randomized Controlled Trials as Topic; Serotonin; Serotonin Antagonists | 1989 |
Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison with amitriptyline and placebo in healthy men.
Topics: Adult; Amitriptyline; Antidepressive Agents; Arousal; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Male; Paroxetine; Piperidines; Psychomotor Performance; Randomized Controlled Trials as Topic; Serotonin Antagonists | 1989 |
Paroxetine: lack of effect on the tyramine pressor response in man.
Topics: Administration, Oral; Adult; Amitriptyline; Antidepressive Agents; Arousal; Blood Pressure; Double-Blind Method; Humans; Male; Norepinephrine; Paroxetine; Piperidines; Randomized Controlled Trials as Topic; Serotonin Antagonists; Tyramine | 1989 |
The effect of paroxetine on the quantitative EEG.
Topics: Adult; Amitriptyline; Antidepressive Agents; Arousal; Cerebral Cortex; Clinical Trials as Topic; Electroencephalography; Evoked Potentials; Female; Humans; Male; Paroxetine; Piperidines; Serotonin Antagonists | 1989 |
Paroxetine in the treatment of depression--a randomized comparison with amitriptyline.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Random Allocation; Serotonin Antagonists | 1985 |
Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study).
Topics: Adolescent; Adult; Amitriptyline; Arrhythmias, Cardiac; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Humans; Male; Middle Aged; Paroxetine; Piperidines; Psychiatric Status Rating Scales | 1985 |
Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Electroencephalography; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Sleep, REM; Wakefulness | 1995 |
Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers.
Topics: Adult; Amitriptyline; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Psychomotor Performance; Sleep; Surveys and Questionnaires; Time Factors | 1995 |
Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients.
Topics: Aged; Aging; Amitriptyline; Depression; Double-Blind Method; Female; Humans; Male; Paroxetine; Time Factors | 1995 |
The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Drug Administration Schedule; Electrocardiography; Female; Fluvoxamine; Heart Rate; Humans; Male; Middle Aged; Paroxetine | 1994 |
A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
Topics: Adolescent; Adult; Aged; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Treatment Outcome | 1994 |
Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Female; Heart Rate; Humans; Male; Middle Aged; Paroxetine | 1994 |
Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
Topics: Amitriptyline; Depressive Disorder; Double-Blind Method; Humans; Paroxetine; Psychiatric Status Rating Scales | 1993 |
Paroxetine and amitriptyline in the treatment of depression in general practice.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Denmark; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Family Practice; Female; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Treatment Outcome | 1996 |
Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Lithium; Male; Middle Aged; Paroxetine | 1999 |
A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Australia; Chi-Square Distribution; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome | 1999 |
[A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Breast Neoplasms; Depressive Disorder; Double-Blind Method; Female; Humans; Middle Aged; Paroxetine; Personality Inventory; Sick Role | 2000 |
Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Arthritis, Rheumatoid; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Treatment Outcome | 2000 |
Neurophysiologic tests during antidepressive treatment - an exploratory study.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Autonomic Nervous System; Depressive Disorder, Major; Doxepin; Female; Fluvoxamine; Heart Rate; Humans; Male; Middle Aged; Neural Conduction; Paroxetine; Psychometrics; Reaction Time; Reflex; Selective Serotonin Reuptake Inhibitors | 2000 |
The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people.
Topics: Affect; Aged; Amitriptyline; Antidepressive Agents; Desipramine; Double-Blind Method; Female; Gait; Humans; Male; Paroxetine; Psychomotor Performance; Risk Factors; Selective Serotonin Reuptake Inhibitors | 2001 |
Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antimanic Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Chloride; Male; Middle Aged; Paroxetine; Statistics, Nonparametric; Tremor | 2001 |
Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Breast Neoplasms; Depression; Double-Blind Method; Female; Humans; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Time Factors; Treatment Outcome | 2001 |
Amitriptyline and paroxetine: effects upon peripheral nervous system (PNS).
Topics: Adult; Aged; Amitriptyline; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Motor Neurons; Neural Conduction; Paroxetine; Peripheral Nerves; Reaction Time; Sensory Receptor Cells | 2002 |
Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.
Topics: Adult; Amitriptyline; Antidepressive Agents; Attention; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Electrooculography; Evoked Potentials; Female; Humans; Male; Memory; Neuropsychological Tests; Paroxetine; Piperazines; Reaction Time; Task Performance and Analysis; Triazoles | 2002 |
[Correction of affective disorders in patients with alcohol dependence].
Topics: Adult; Alcoholism; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Humans; Middle Aged; Military Personnel; Mood Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2002 |
Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations.
Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Paroxetine; Pituitary-Adrenal System; Psychiatric Status Rating Scales; Saliva; Treatment Outcome | 2003 |
Platelet counts in depressed patients treated with amitriptyline or paroxetine.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Paroxetine; Platelet Count; Selective Serotonin Reuptake Inhibitors | 2003 |
Treating chronic tension-type headache not responding to amitriptyline hydrochloride with paroxetine hydrochloride: a pilot evaluation.
Topics: Adult; Amitriptyline; Analgesics; Antidepressive Agents, Tricyclic; Chronic Disease; Double-Blind Method; Female; Humans; Male; Paroxetine; Pilot Projects; Serotonin Receptor Agonists; Tension-Type Headache; Treatment Failure | 2003 |
Impaired declarative memory in depressed patients is slow to recover: clinical experience.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrocortisone; Language Tests; Male; Memory Disorders; Middle Aged; Paroxetine; Recovery of Function; Remission Induction; Saliva; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Verbal Learning | 2004 |
Open-label non-randomized versus double-blind randomized antidepressive treatment: what are the advantages of clinical decision over randomization?
Topics: Adult; Aged; Amitriptyline; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Psychiatric Status Rating Scales; Retrospective Studies; Treatment Outcome | 2004 |
[Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences].
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Data Interpretation, Statistical; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Quality of Life; Recurrence; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome | 2005 |
Hippocampal volume reduction and HPA-system activity in major depression.
Topics: Adult; Age Factors; Aged; Amitriptyline; Antidepressive Agents; Cephalometry; Depressive Disorder, Major; Dominance, Cerebral; Female; Follow-Up Studies; Hippocampus; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Image Processing, Computer-Assisted; Length of Stay; Magnetic Resonance Imaging; Male; Middle Aged; Paroxetine; Personality Inventory; Saliva; Statistics as Topic | 2007 |
Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Hypoglycemic Agents; Hypothalamo-Hypophyseal System; Insulin; Insulin Resistance; Male; Middle Aged; Paroxetine; Pituitary-Adrenal System; Risk Factors; Saliva | 2006 |
Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain-Derived Neurotrophic Factor; Depressive Disorder; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Middle Aged; Nerve Growth Factor; Paroxetine; Psychiatric Status Rating Scales; Saliva | 2008 |
The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Asian People; Automobile Driving; Cognition; Cross-Over Studies; Double-Blind Method; Humans; Japan; Male; Paroxetine; Psychomotor Performance; Reaction Time | 2008 |
Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Paroxetine; Secondary Prevention | 2010 |
Treatment with paroxetine, but not amitriptyline, lowers levels of lipoprotein(a) in patients with major depression.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Lipoprotein(a); Male; Middle Aged; Paroxetine | 2011 |
Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Biomarkers; Body Mass Index; Cyclohexanols; Depression; Female; Humans; Leptin; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Time Factors; Treatment Outcome; Up-Regulation; Venlafaxine Hydrochloride; Weight Gain; Young Adult | 2013 |
The effects of acute treatment with paroxetine, amitriptyline, and placebo on the equilibrium function in healthy subjects: a double-blind crossover trial.
Topics: Accidental Falls; Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Cross-Over Studies; Diagnosis, Computer-Assisted; Double-Blind Method; Humans; Male; Paroxetine; Placebos; Postural Balance; Vestibular Function Tests | 2014 |
Comparative Efficacy of Newer Antidepressants in Combination with Pregabalin for Fibromyalgia Syndrome: A Controlled, Randomized Study.
Topics: Adult; Amitriptyline; Antidepressive Agents; Depression; Drug Therapy, Combination; Female; Fibromyalgia; Humans; Male; Middle Aged; Paroxetine; Pregabalin; Quality of Life; Venlafaxine Hydrochloride | 2017 |
Comparison of paroxetine and amitriptyline in the treatment of refractory globus pharyngeus.
Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety; China; Depression; Double-Blind Method; Female; Humans; Lansoprazole; Male; Middle Aged; Paroxetine; Pharyngeal Diseases; Prospective Studies; Proton Pump Inhibitors; Psychiatric Status Rating Scales; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2016 |
The effects of paroxetine and amitriptyline on the upper esophageal sphincter (UES) pressure and its natural history in globus pharyngeus.
Topics: Adult; Amitriptyline; Antidepressive Agents; Esophageal Sphincter, Upper; Female; Humans; Lansoprazole; Male; Manometry; Middle Aged; Paroxetine; Pharyngeal Diseases; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires | 2017 |
Serotonin Transporter Gene (SLC6A4) Polymorphism May Be Associated with Chinese Globus Pharyngeus and Its Antidepressant Effects.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; China; Conversion Disorder; Deglutition Disorders; Female; Genotyping Techniques; Humans; Male; Manometry; Middle Aged; Paroxetine; Patient Health Questionnaire; Pharyngeal Diseases; Polymorphism, Genetic; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome; Young Adult | 2018 |
70 other study(ies) available for paroxetine and amitriptyline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Carrier Proteins; Colony-Forming Units Assay; Conditioning, Operant; Cyclic AMP; HeLa Cells; Humans; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; Piperazines; Radioligand Assay; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Thiophenes | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Topics: Absorption; Albumins; Animals; Brain; Brain Chemistry; Cell Membrane; Chromatography, High Pressure Liquid; Drug Evaluation, Preclinical; In Vitro Techniques; Lipids; Male; Microdialysis; Pharmaceutical Preparations; Protein Binding; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swine; Tissue Distribution | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effect of paroxetine, a selective 5-hydroxytryptamine uptake inhibitor, on beta-adrenoceptors in rat brain: autoradiographic and functional studies.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Animals; Autoradiography; Brain Chemistry; Cyclic AMP; Desipramine; Iodine Radioisotopes; Iodocyanopindolol; Kinetics; Male; Membranes; Paroxetine; Pindolol; Piperidines; Propanolamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Serotonin Antagonists | 1991 |
Effect of prolonged 5-hydroxytryptamine uptake inhibition by paroxetine on cortical beta 1 and beta 2-adrenoceptors in rat brain.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Animals; Antidepressive Agents; Cerebral Cortex; Dose-Response Relationship, Drug; Imidazoles; Kinetics; Male; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Propanolamines; Radioligand Assay; Rats; Receptors, Adrenergic, beta; Receptors, Serotonin; Serotonin | 1990 |
Antidepressants and the peripheral nervous system.
Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Electromyography; Humans; Neural Conduction; Paroxetine; Peripheral Nerves; Piperidines; Serotonin Antagonists | 1989 |
Pharmacological effects of paroxetine after repeated administration to animals.
Topics: Amitriptyline; Animals; Antidepressive Agents; Brain; Cerebral Cortex; Male; Paroxetine; Piperidines; Radioligand Assay; Rats; Receptors, Serotonin; Serotonin Antagonists | 1989 |
Relative lack of cardiotoxicity of paroxetine in animal models.
Topics: Amitriptyline; Animals; Antidepressive Agents; Blood Pressure; Cats; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Conduction System; Heart Rate; Paroxetine; Piperidines; Serotonin Antagonists | 1989 |
Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
Topics: 5-Methoxytryptamine; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Citalopram; Electric Stimulation; Fenclonine; Hypothalamus; Imipramine; Lysergic Acid Diethylamide; Male; Methiothepin; Neurotransmitter Agents; Pargyline; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1985 |
Comparison of some effects of paroxetine with amitriptyline on the cardiovascular system in animals.
Topics: Amitriptyline; Animals; Antidepressive Agents; Cats; Drug Evaluation, Preclinical; Electrocardiography; Female; Heart Conduction System; Hypotension; Infusions, Parenteral; Male; Myocardial Contraction; Paroxetine; Piperidines; Rabbits; Seizures; Serotonin Antagonists; Tachycardia | 1986 |
High- and low-affinity binding of [3H]imipramine in rat hypothalamus.
Topics: Amitriptyline; Animals; Citalopram; Clomipramine; Cyclopropanes; Hypothalamus; Imipramine; Kinetics; Male; Milnacipran; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Sodium | 1986 |
Cardiovascular effects of paroxetine, a newly developed antidepressant, in anesthetized dogs in comparison with those of imipramine, amitriptyline and clomipramine.
Topics: Amitriptyline; Anesthesia; Animals; Antidepressive Agents; Atrioventricular Node; Blood Pressure; Clomipramine; Dogs; Electrocardiography; Female; Heart Conduction System; Heart Rate; Hemodynamics; Imipramine; Male; Paroxetine; Piperidines; Respiration | 1987 |
Electroencephalographic effects of the new antidepressant paroxetine in the rabbit.
Topics: Amitriptyline; Animals; Antidepressive Agents; Arousal; Drug Interactions; Electric Stimulation; Electroencephalography; Limbic System; Male; Paroxetine; Photic Stimulation; Physostigmine; Piperidines; Rabbits; Recruitment, Neurophysiological | 1988 |
A comparison of the effect of paroxetine and amitriptyline on the tyramine pressor response test.
Topics: Adult; Amitriptyline; Blood Pressure; Humans; Hypnotics and Sedatives; Male; Paroxetine; Piperidines; Serotonin Antagonists; Tyramine | 1985 |
[Fluoxetine in perspective].
Topics: Amitriptyline; Depression; Double-Blind Method; Fluoxetine; Humans; Paroxetine | 1994 |
Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.
Topics: Amitriptyline; Animals; Brain Chemistry; Calcimycin; Calcium; Cerebral Cortex; Female; Fluoxetine; Guinea Pigs; In Vitro Techniques; Inositol; Ketanserin; Male; Paroxetine; Phosphatidylinositols; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1993 |
The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva.
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Dothiepin; Female; Fluoxetine; Humans; Male; Middle Aged; Muscarinic Antagonists; Parotid Gland; Paroxetine; Potassium; Prospective Studies; Receptors, Muscarinic; Retrospective Studies; Saliva; Secretory Rate; Selective Serotonin Reuptake Inhibitors; Sodium; Xerostomia | 1995 |
Effect of valine on 5-HT neurotransmission and mood.
Topics: 1-Naphthylamine; Adult; Affect; Amino Acids, Branched-Chain; Amitriptyline; Analysis of Variance; Antidepressive Agents; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fenfluramine; Humans; Lithium; Male; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Valine | 1996 |
Sleep-related painful erections: clinical and polysomnographic features.
Topics: Adrenergic beta-Antagonists; Adult; Amitriptyline; Humans; Lorazepam; Male; Middle Aged; Narcolepsy; Paroxetine; Penile Erection; Polysomnography; Propranolol; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sexual Dysfunctions, Psychological; Sleep Stages; Sleep, REM | 1996 |
The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice.
Topics: Amitriptyline; Animals; Antidepressive Agents; Benzopyrans; Cromakalim; Desipramine; Drug Interactions; Imipramine; Locomotion; Male; Mianserin; Mice; Minoxidil; Paroxetine; Physical Exertion; Potassium Channels; Pyrroles; Swimming | 1996 |
Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Amitriptyline; Animals; Clomipramine; Cyclohexanols; Male; Neurons; Paroxetine; Piperazines; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 1997 |
The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds.
Topics: Abdominal Muscles; Acetic Acid; Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclobutanes; Dothiepin; Male; Maprotiline; Mice; Muscle Contraction; Naloxone; Naltrexone; Narcotic Antagonists; Neprilysin; Neurotransmitter Uptake Inhibitors; Opioid Peptides; Pain Measurement; Paroxetine; Protease Inhibitors; Receptors, Opioid; Selective Serotonin Reuptake Inhibitors; Thiorphan | 1998 |
Tricyclic antidepressants in adolescent depression. A case report.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Child; Depressive Disorder; Dothiepin; Drug Monitoring; Drug Therapy, Combination; Electrocardiography; Humans; Lithium Carbonate; Lofepramine; Male; Paroxetine; Trazodone | 1998 |
Chronic amitriptyline administration increases serotonin transporter binding sites in the hippocampus of aged rats.
Topics: Aging; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Binding Sites; Carrier Proteins; Dentate Gyrus; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Rats; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Up-Regulation | 1999 |
Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds?
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Animals; Antidepressive Agents; Cyclobutanes; Dothiepin; Drug Interactions; Male; Maprotiline; Mice; Norepinephrine; Pain Measurement; Paroxetine; Random Allocation; Receptors, Adrenergic; Selective Serotonin Reuptake Inhibitors | 1999 |
Economic appraisal of citalopram in the management of single-episode depression.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Health Maintenance Organizations; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Retrospective Studies; Sertraline | 1999 |
Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Cells, Cultured; Desipramine; Dexamethasone; Gene Expression Regulation; Haloperidol; Hippocampus; Ketanserin; Mianserin; Neurons; Paroxetine; Phentolamine; Propranolol; Radioligand Assay; Rats; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; RNA, Messenger; Sulpiride; Transcription, Genetic; Tritium | 1999 |
Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants.
Topics: Adult; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Cathartics; Cholinergic Antagonists; Clomipramine; Colon; Colonoscopy; Constipation; Depressive Disorder; Eating; Fecal Impaction; Female; Gastrointestinal Motility; Humans; Male; Manometry; Maprotiline; Middle Aged; Mood Disorders; Muscle Contraction; Paroxetine; Selective Serotonin Reuptake Inhibitors; Thiazepines; Viloxazine | 2000 |
Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Female; Humans; Leptin; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nortriptyline; Paroxetine; Receptors, Leptin; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2000 |
Do antidepressants affect motivation in conditioned place preference?
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclobutanes; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Male; Motivation; Norepinephrine; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Antidepressant treatment and global tests of coagulation and fibrinolysis.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Blood Coagulation Tests; Depressive Disorder; Female; Fibrinogen; Fibrinolysis; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2001 |
Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability.
Topics: Adult; Amitriptyline; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2001 |
Salmon calcitonin potentiates the analgesia induced by antidepressants.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Brain Chemistry; Calcitonin; Depression; Dose-Response Relationship, Drug; Drug Synergism; Hydroxyindoleacetic Acid; Male; Mice; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming | 2001 |
Pharmacological heterogeneity limits antidepressant study.
Topics: Amitriptyline; Antidepressive Agents; Depressive Disorder; Humans; Mianserin; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2003 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Antidepressants and the risk of suicidal behaviors.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Amitriptyline; Antidepressive Agents; Case-Control Studies; Child; Dothiepin; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Risk; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted; United Kingdom | 2004 |
Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Blood Glucose; Body Mass Index; Cholesterol; Circadian Rhythm; Coronary Disease; Depressive Disorder, Major; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin Resistance; Lipids; Lipoproteins; Male; Metabolic Syndrome; Middle Aged; Obesity; Paroxetine; Pituitary-Adrenal System; Risk Factors; Triglycerides | 2004 |
Antidepressant treatment and dehydroepiandrosterone sulfate: different effects of amitriptyline and paroxetine.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Dehydroepiandrosterone Sulfate; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine | 2004 |
Antidepressants and the risk of suicidal behaviors.
Topics: Amitriptyline; Antidepressive Agents; Dothiepin; Fluoxetine; Humans; Paroxetine; Risk; Selective Serotonin Reuptake Inhibitors; Suicide | 2004 |
Antidepressants and suicide: a commentary on a significant contribution to this debate.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Child; Depression; Dothiepin; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted; Time Factors; United Kingdom | 2005 |
A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Brain; Cyclohexanols; Desipramine; Male; Norepinephrine Plasma Membrane Transport Proteins; Paroxetine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Venlafaxine Hydrochloride | 2006 |
Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression.
Topics: Adult; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antimanic Agents; Depressive Disorder, Major; Female; Humans; Methadone; Mood Disorders; Narcotics; Opipramol; Paroxetine; Prazepam; Psychiatric Status Rating Scales; Serotonin Syndrome; Severity of Illness Index; Substance-Related Disorders; Transcranial Magnetic Stimulation; Trazodone; Valproic Acid | 2006 |
[A comparative study of efficacy and tolerability of antidepressants from different classes in mild and moderate depression].
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Depression; Drug Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Severity of Illness Index; Thiazepines; Treatment Outcome | 2006 |
Associations between the use of common medications and sleep architecture in patients with untreated obstructive sleep apnea.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Antidepressive Agents; Aspirin; Drug Therapy; Female; Fluoxetine; Health Status; Humans; Male; Middle Aged; Paroxetine; Polysomnography; Retrospective Studies; Sleep Apnea, Obstructive; Sleep, REM; Treatment Refusal | 2006 |
The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Clozapine; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Investigational; Fluoxetine; Guinea Pigs; Injections, Intraperitoneal; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Swimming; Tranylcypromine | 2007 |
Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Case-Control Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sex Factors | 2009 |
Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass Index; Case-Control Studies; Cyclohexanols; Depressive Disorder; Diabetes Mellitus; Female; Fluvoxamine; Humans; Incidence; Male; Middle Aged; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Time Factors; United Kingdom; Venlafaxine Hydrochloride | 2009 |
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger | 2009 |
A rare case of male hysteria - hemiparesis successfully treated with amitriptyline.
Topics: Adult; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Bromazepam; Depressive Disorder, Major; Humans; Hysteria; Lorazepam; Magnetic Resonance Imaging; Male; Paresis; Paroxetine; Treatment Outcome | 2011 |
Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans.
Topics: Adult; Amitriptyline; Animals; Antidepressive Agents; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Blood Cells; Depression; Depressive Disorder; Female; Humans; Leukocytes, Mononuclear; Male; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Paroxetine; Rats, Sprague-Dawley; Stress, Psychological; Tacrolimus Binding Proteins; Young Adult | 2014 |
FKBP5/FKBP51 enhances autophagy to synergize with antidepressant action.
Topics: Amitriptyline; Animals; Antidepressive Agents; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Behavior, Animal; Depression; Electrophysiology; Gene Expression Regulation; HSP90 Heat-Shock Proteins; Humans; Immunoprecipitation; Membrane Proteins; Mice; Molecular Chaperones; Paroxetine; Phosphorylation; Tacrolimus Binding Proteins | 2015 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Tolerance; Female; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride; Young Adult | 2015 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
Storage of urine specimens in point of care (POC) urine drug testing cups reduces concentrations of many drugs.
Topics: Amitriptyline; Chromatography, Liquid; Drug Storage; Fentanyl; Flunitrazepam; Fluoxetine; Humans; Mass Spectrometry; Nortriptyline; Paroxetine; Point-of-Care Testing; Sertraline | 2019 |
A stereological study of the effects of antidepressants on postmenopausal rat kidney.
Topics: Amitriptyline; Animals; Antidepressive Agents; Female; Kidney; Ovariectomy; Paroxetine; Rats; Rats, Sprague-Dawley | 2020 |
Combining threshold analysis and GRADE to assess sensitivity to bias in antidepressant treatment recommendations adjusted for depression severity.
Topics: Acetamides; Adult; Amitriptyline; Antidepressive Agents; Bayes Theorem; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Network Meta-Analysis; Paroxetine; Publication Bias; Reproducibility of Results; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2.
Topics: Adenosine Diphosphate Ribose; Amitriptyline; Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Fluoxetine; HEK293 Cells; Hot Temperature; Humans; Ketamine; Lidocaine; Mice; Paroxetine; Pregabalin; Sertraline; TRPM Cation Channels | 2022 |
Anticancer effect of paroxetine and amitriptyline on HT29 and A549 cell lines.
Topics: A549 Cells; Amitriptyline; Antidepressive Agents, Tricyclic; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2023 |